#大药 #拉罗替尼
拉罗替尼（larotrectinib）与NTRK基因融合
神经营养性酪氨酸受体激酶（NTRK）是目前首个被发现并被认可的全癌种共发的可用药的突变基因，在多种肿瘤中都有发现，在常见肿瘤肺癌、结直肠癌中的发病率低于5%，但多出现于成人和儿童实体瘤中，包括乳腺类似物分泌癌（MASC）、甲状腺癌、结肠癌、肺癌、
BY 印度、日本、孟加拉药物代购 （首单支持顺丰到付）
Among the actives, Ascendas REIT sank 0.64 percent, while CapitaLand Integrated Commercial Trust plummeted 1.42 percent, City Developments plunged 1.12 percent, Dairy Farm International tumbled 0.86 percent, DBS Group skidded 0.68 percent, Genting Singapore retreated 0.67 percent, Hongkong Land climbed 1.30 percent, Mapletree Commercial Trust lost 0.47 percent, Mapletree Logistics Trust tanked 0.95 percent, Oversea-Chinese Banking Corporation dropped 0.61 percent, SATS rose 0.24 percent, SembCorp Industries shed 0.54 percent, Singapore Airlines surrendered 0.79 percent, Singapore Exchange slid 0.30 percent, Singapore Press Holdings declined 1.03 percent, Singapore Technologies Engineering dipped 0.26 percent, SingTel advanced 0.81 percent, United Overseas Bank fell 0.39 percent, Wilmar International eased 0.24 percent, Yangzijiang Shipbuilding jumped 1.42 percent and Keppel Corp, Thai Beverage, CapitaLand and Comfort DelGro were unchanged.
印度、日本、孟加拉药物代购 首单支持顺丰到付 from us